Angela Bechini, Beatrice Zanella, Benedetta Bonito, Marta Betti, Enrica Stancanelli, Marco Del Riccio, Cristina Salvati, Paolo Bonanni, Jacopo Bianchi, Ilaria Biondi, Martina Chellini, Maddalena Innocenti, Federico Manzi, Diana Paolini, Gino Sartor, Lorenzo Baggiani, Simona Baretti, Monica Della Fonte, Giorgio Garofalo, Giovanna Mereu, Maria Grazia Santini, Sara Boccalini
{"title":"Anti-rubella seroprevalence assessment in an adult sample population in Italy.","authors":"Angela Bechini, Beatrice Zanella, Benedetta Bonito, Marta Betti, Enrica Stancanelli, Marco Del Riccio, Cristina Salvati, Paolo Bonanni, Jacopo Bianchi, Ilaria Biondi, Martina Chellini, Maddalena Innocenti, Federico Manzi, Diana Paolini, Gino Sartor, Lorenzo Baggiani, Simona Baretti, Monica Della Fonte, Giorgio Garofalo, Giovanna Mereu, Maria Grazia Santini, Sara Boccalini","doi":"10.7416/ai.2024.2632","DOIUrl":null,"url":null,"abstract":"<p><strong>Introduction: </strong>Despite global immunization efforts, rubella remains a public health concern, particularly in high- and middle-income countries. This study focused on rubella seroprevalence in the province of Florence, Italy, aiming to identify susceptibility clusters, especially among women in their childbearing age.</p><p><strong>Methods: </strong>A cross-sectional study was conducted between April 2018 and December 2019, enrolling 430 adult subjects (age over 18 years). Serum samples were collected, and anti-rubella antibodies were quantified using the ELISA test. Data were analyzed descriptively and compared by sex, nationality, and age groups using statistical tests.</p><p><strong>Results: </strong>The overall rubella seroprevalence was high (92.3%), with no significant differences between genders or nationalities. Among childbearing-age females (18-49 years), the highest seroprevalence was observed in the 30-39 age group (94.1%). However, susceptibility clusters exceeding the 5% threshold set by WHO were identified, especially in females aged 40-49 years (7.0%).</p><p><strong>Conclusions: </strong>Despite high overall seroprevalence, the study identified pockets of susceptibility, even in childbearing age women. Continuous monitoring, targeted immunization strategies, and public health interventions are recommended to maintain rubella elimination, emphasizing the importance of sustained vaccination efforts to protect vulnerable populations.</p>","PeriodicalId":7999,"journal":{"name":"Annali di igiene : medicina preventiva e di comunita","volume":null,"pages":null},"PeriodicalIF":1.5000,"publicationDate":"2024-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Annali di igiene : medicina preventiva e di comunita","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.7416/ai.2024.2632","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/5/2 0:00:00","PubModel":"Epub","JCR":"Q3","JCRName":"HEALTH CARE SCIENCES & SERVICES","Score":null,"Total":0}
引用次数: 0
Abstract
Introduction: Despite global immunization efforts, rubella remains a public health concern, particularly in high- and middle-income countries. This study focused on rubella seroprevalence in the province of Florence, Italy, aiming to identify susceptibility clusters, especially among women in their childbearing age.
Methods: A cross-sectional study was conducted between April 2018 and December 2019, enrolling 430 adult subjects (age over 18 years). Serum samples were collected, and anti-rubella antibodies were quantified using the ELISA test. Data were analyzed descriptively and compared by sex, nationality, and age groups using statistical tests.
Results: The overall rubella seroprevalence was high (92.3%), with no significant differences between genders or nationalities. Among childbearing-age females (18-49 years), the highest seroprevalence was observed in the 30-39 age group (94.1%). However, susceptibility clusters exceeding the 5% threshold set by WHO were identified, especially in females aged 40-49 years (7.0%).
Conclusions: Despite high overall seroprevalence, the study identified pockets of susceptibility, even in childbearing age women. Continuous monitoring, targeted immunization strategies, and public health interventions are recommended to maintain rubella elimination, emphasizing the importance of sustained vaccination efforts to protect vulnerable populations.